CHRISTOPHER J HUERTER
Allopathic & Osteopathic Physicians|Dermatology OMAHA, NE NPI 1801906326
Browse related groups: Allopathic & Osteopathic Physicians|Dermatology NE Lilly USA, LLC All categories
General Payments — all program years on this page
$6,659.94
- Category: General Payments
- Program years: PY2018–2024
- Record count: 400
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,367.00 across 67 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,367.00 | 67 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $186.49 | 9 |
| ABBVIE INC. | $176.22 | 7 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $121.94 | 6 |
| Incyte Corporation | $113.72 | 5 |
| Regeneron Healthcare Solutions, Inc. | $90.88 | 3 |
| Amgen Inc. | $86.29 | 4 |
| Dermavant Sciences, Inc. | $80.08 | 5 |
| E.R. Squibb & Sons, L.L.C. | $77.41 | 5 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $63.35 | 3 |
| GENZYME CORPORATION | $60.47 | 3 |
| UCB, Inc. | $55.99 | 3 |
| Sandoz Inc. | $50.30 | 3 |
| Galderma Laboratories, L.P. | $41.96 | 2 |
| Janssen Biotech, Inc. | $38.96 | 2 |
| PFIZER INC. | $27.59 | 2 |
| Genentech USA, Inc. | $24.82 | 1 |
| LEO Pharma Inc. | $22.77 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.06 | 1 |
| Teva Pharmaceuticals USA, Inc. | $14.21 | 1 |
| ANI Pharmaceuticals, Inc. | $13.49 | 1 |
By program year
Records — PY2024 (67)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.